| Dr Mily Nieves, MD | |
|
1142 E Southern Ave Ste 101, Mesa, AZ 85204-5056 | |
| (480) 821-3600 | |
| (480) 857-2667 |
| Full Name | Dr Mily Nieves |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 1142 E Southern Ave Ste 101, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508901612 | NPI | - | NPPES |
| 9010093 | Other | ABOG BOARD CERTIFIED | |
| 222419 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 36917 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Momdoc Llc | 3375534282 | 14 |
News Archive
Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has been dosed in a Phase 1 clinical trial of IGN523 in patients with relapsed or refractory acute myeloid leukemia (AML).
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
› Verified 3 days ago
| Entity Name | Momdoc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184780355 PECOS PAC ID: 3375534282 Enrollment ID: O20040520000050 |
News Archive
Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has been dosed in a Phase 1 clinical trial of IGN523 in patients with relapsed or refractory acute myeloid leukemia (AML).
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mily Nieves, MD Po Box 6730, Chandler, AZ 85246-6730 Ph: (480) 821-3600 | Dr Mily Nieves, MD 1142 E Southern Ave Ste 101, Mesa, AZ 85204-5056 Ph: (480) 821-3600 |
News Archive
Igenica Biotherapeutics, a company focused on the discovery and development of innovative antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that the first patient has been dosed in a Phase 1 clinical trial of IGN523 in patients with relapsed or refractory acute myeloid leukemia (AML).
22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, announced today that the company licensed Hercules Pharmaceuticals LLC, its wholly-owned pharmaceutical subsidiary, exclusive worldwide rights to X-22.
Rush University, in partnership with the University HealthSystem Consortium (UHC), has been awarded a three-year, $500,000 Market Development Cooperative Grant from the U.S. Department of Commerce to help boost medical travel to U.S. academic medical centers.
Navigenics, a leading personal genomics company, announced today that The New England Journal of Medicine has published findings from the Scripps Genomic Health Initiative, a research study sponsored by Scripps Translational Science Institute to assess the behavioral impact of personal genetic testing.
› Verified 3 days ago
Mrs. Eericca Michelle Bickley, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4824 E Baseline Rd Ste 129, Mesa, AZ 85206 Phone: 480-644-1001 Fax: 480-644-1002 | |
Gregory D Layton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4824 E Baseline Rd Ste 129, Mesa, AZ 85206 Phone: 480-644-1001 Fax: 480-464-8722 | |
Deanna Lynn Bullaro-anderer, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5304 E Southern Ave, Ste 110, Mesa, AZ 85206 Phone: 480-237-3040 Fax: 480-237-3049 | |
Andrew R Adamson, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 455 E 6th St, Mesa, AZ 85203 Phone: 480-844-4702 | |
Marlin D. Mills, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1940 S Country Club Dr, Suite 102, Mesa, AZ 85210 Phone: 680-969-5999 Fax: 480-969-5610 | |
Dr. Carlos Alberto Mendez, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1705 W Main St, Mesa, AZ 85201 Phone: 877-809-5092 Fax: 480-840-1758 | |
Ronald C Burton, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1432 S Dobson Rd, Ste 509, Mesa, AZ 85202 Phone: 480-834-5111 Fax: 480-834-5222 |